Title:
HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2019/120296
Kind Code:
A1
Abstract:
The present invention relates to heterocyclic compounds as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition comprising said compound.
Inventors:
WANG ZHAOYIN (CN)
LI NANXIN (US)
MA JIANBIN (CN)
SHAO YANQIANG (CN)
LI NANXIN (US)
MA JIANBIN (CN)
SHAO YANQIANG (CN)
Application Number:
PCT/CN2018/122815
Publication Date:
June 27, 2019
Filing Date:
December 21, 2018
Export Citation:
Assignee:
GUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
C07F5/02; A61K31/69; A61P13/12; A61P27/02; A61P31/00; A61P35/00; A61P37/02; C07F5/04
Domestic Patent References:
| WO2012058065A1 | 2012-05-03 | |||
| WO2016210106A1 | 2016-12-29 | |||
| WO2013158262A1 | 2013-10-24 | |||
| WO2017075363A1 | 2017-05-04 |
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: